This is a community-generated profile. If you would like to claim it, please .
Adimab Funding
$39.7M
88 rounds
Adimab is active in the following markets / industries: biotechnology. The company has secured funding across 8 rounds, totaling in an amount of $39.7M. Their most recent funding was raised on April 3, 2012.
Funding Rounds
U
$14000000UnknownApr 2012
U
$4000000D
$8200000C
$4000000B
$3180000A
$5900000U
$2384A
$400000Investors of Adimab
Distinguished Engineer at @Google (One of first 10 employees); PM & Strategy on Gmail, GTalk, Video, @Picasa, Orkut, Groups & Mobile. Co-dev of AdSense targeting.
John Platts
Actively founding, financing and supporting high growth companies through investments and professional support.
OrbiMed
Borealis Ventures
Rounds
D
SV Life Sciences
Rounds
U
D
A
OrbiMed Advisors
Rounds
D
GV provides venture capital funding to bold new companies
Rounds
U
D
Co-founder of @Borealis Ventures. Seed/early-stage investor in @Adimab, @Avedro, @Avitide, @Vetsfirstchoice, @GlycoFi, @Teckro, etc. VC prof at Dartmouth.
Tech and Life Science Venture Capital
Rounds
U
D
C
A
A